Breast Cancer News and Research

Latest Breast Cancer News and Research

Bazedoxifene used for treating osteoporosis stops growth of breast cancer cells

A drug approved in Europe to treat osteoporosis has now been shown to stop the growth of breast cancer cells, even in cancers that have become resistant to current targeted therapies, according to a Duke Cancer Institute study.

17 Jun 2013

Ambrx, ZMC partner to develop and commercialize ARX788 for treatment of Her2-positive breast cancer

Ambrx and Zhejiang Medicine Co. Ltd. today announced that they have formed a collaboration to develop and commercialize ARX788, Ambrx's most advanced internally developed site-specific antibody drug conjugate targeting Her2-positive breast cancer.

17 Jun 2013

Pathway Genomics to provide genetic testing for BRCA gene linked to breast, ovarian cancers

Pathway Genomics led the evening news Friday with an announcement that it could begin offering affordable access to genetic testing for the BRCA gene linked to breast and ovarian cancers in the wake of a Supreme Court ruling that eliminated another company's monopoly on the test.

15 Jun 2013

In unanimous decision, Supreme Court justices rule genes can't be patented

The decision was applauded by many researchers and drew speculation that it could likely boost patient care. Meanwhile, the stock of Myriad Genetics tumbled after the court's finding invalidated the company's hold on testing for two breast cancer genes.

15 Jun 2013

Adults formerly treated for childhood cancer have chronic health problems

In an analysis that included more than 1,700 adult survivors of childhood cancer, researchers found a very high percentage of survivors with 1 or more chronic health conditions, with an estimated cumulative prevalence of any chronic health condition of 95 percent at age 45 years, according to a study in the June 12 issue of JAMA.

14 Jun 2013

Gene variants may predict which women are most likely to benefit from breast cancer therapy

In women at high risk for breast cancer, a long-term drug treatment can cut the risk of developing the disease in half. Researchers supported by the National Institutes of Health have now identified two gene variants that may predict which women are most likely to benefit from this therapy—and which should avoid it.

14 Jun 2013

Protein expressed during embryogenesis is responsible for cancer metastasis

A protein used by embryo cells during early development, and recently found in many different types of cancer, apparently serves as a switch regulating the spread of cancer, known as metastasis, report researchers at the University of California, San Diego School of Medicine and UC San Diego Moores Cancer Center in the June 15, 2013 issue of the journal Cancer Research.

14 Jun 2013

First Edition: June 14, 2013

Today's headlines includes reports about how, after months of battle, Arizona lawmakers endorsed a Medicaid expansion plan backed by Gov. Jan Brewer.

14 Jun 2013

Genetic variations may help predict breast cancer risk in women who receive preventive therapy

Newly discovered genetic variations may help predict breast cancer risk in women who receive preventive breast cancer therapy with the selective estrogen receptor modulator drugs tamoxifen and raloxifene, a Mayo Clinic-led study has found. The study is published in the journal Cancer Discovery.

14 Jun 2013

Findings provide basis for reinvigoration of research efforts in breast cancer prevention

Genetic variations, known as single nucleotide polymorphisms, in or near the genes ZNF423 and CTSO were associated with breast cancer risk among women who underwent prevention therapy with tamoxifen and raloxifene, according to data published in Cancer Discovery, a journal of the American Association for Cancer Research.

14 Jun 2013

Ambry Genetics introduces BRCA1 and BRCA2 analysis

Ambry Genetics announced today the launch of BRCA1 and BRCA2 analysis as part of their comprehensive cancer-testing menu. Two genes will be offered as a stand alone test comprising of full gene sequencing and deletion/duplication analyses in addition to being incorporated as part of multiple hereditary cancer panels that test cancer susceptibility genes using next-generation sequencing technology.

14 Jun 2013

Penn Medicine researchers identify key molecular player in recurrent breast cancer

According to the American Cancer Society, nearly 40,000 women in the United States will succumb to breast cancer this year. Most of these women will die not from the primary tumor but rather tumor recurrence - the reappearance of the disease following treatment.

14 Jun 2013

HEXIM1 gene makes heart healthier, suppresses breast cancer metastasis

Researchers at Case Western Reserve University have found that a single gene poses a double threat to disease: Not only does it inhibit the growth and spread of breast tumors, but it also makes hearts healthier.

14 Jun 2013

Viewpoints: Administration 'finally' comes around on Plan B; 'Legal loophole' creates another compounded drug scare

Reluctantly yielding to a federal-court decision, the Obama administration announced on Monday that it will take steps to allow a version of the so-called morning-after pill, known as Plan B One-Step, to be sold over the counter to girls and women of all ages. They will not need a prescription, nor will they be required to show any identification to obtain the emergency contraceptive. There will be no restrictions on where the drug can be sold; it will be up to the manufacturer to propose appropriate venues (6/11).

13 Jun 2013

Black women with breast cancer experience treatment delays, new study finds

Black women with breast cancer are more likely than Hispanic or white women to experience delays in the initiation of chemotherapy or radiation after surgery, finds a new study in Health Services Research.

13 Jun 2013

Eribulin shows increased benefit among women sharing certain traits

Subgroup analyses from a phase III clinical trial comparing a newer chemotherapy agent called eribulin mesylate, with capecitabine, a standard chemotherapy medication in women with previously treated metastatic breast cancer, showed increased benefit among women sharing certain traits.

13 Jun 2013

Research: Breast cancer screening does not show effect on mortality statistics

New research analysing breast cancer mortality data spanning almost 40 years concludes that breast cancer screening does not yet show an effect on mortality statistics.

12 Jun 2013

Integrating exercise into cancer follow-up care can improve recovery, say Miriam Hospital researchers

Telephone-based counseling, when combined with physician advice, can help breast cancer survivors become more physically active, which can improve quality of life and lessen the side effects of cancer treatment, according to new research from The Miriam Hospital.

12 Jun 2013

PET and MR imaging can improve quality of life and survival for advanced breast cancer patients

For patients with advanced breast cancer, positron emission tomography and magnetic resonance imaging can improve quality of life and survival by providing physicians with information on the effectiveness of chemotherapy prior to surgery, say researchers presenting at the 2013 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging.

12 Jun 2013

Viewpoints: Selling Obamacare in Arizona; 'Hassle-free' marketplace; Seeking the 'grand bargain'

You may not admit it, but you are a fan of Obamacare and Gov. Jan Brewer knows it. The Republicans who run the Arizona legislature don't like Obamacare. And the Republicans who control the U.S. House of Representatives don't like it. But you do. You may deny it. You may not even know it. But you do. And that will help the governor get her Medicaid expansion plan through the legislature (EJ Montini, 6/6).

11 Jun 2013

Breast Cancer News and Research

Latest Breast Cancer News and Research

Bazedoxifene used for treating osteoporosis stops growth of breast cancer cells

Ambrx, ZMC partner to develop and commercialize ARX788 for treatment of Her2-positive breast cancer

Pathway Genomics to provide genetic testing for BRCA gene linked to breast, ovarian cancers

In unanimous decision, Supreme Court justices rule genes can't be patented

Adults formerly treated for childhood cancer have chronic health problems

Gene variants may predict which women are most likely to benefit from breast cancer therapy

Protein expressed during embryogenesis is responsible for cancer metastasis

First Edition: June 14, 2013

Genetic variations may help predict breast cancer risk in women who receive preventive therapy

Findings provide basis for reinvigoration of research efforts in breast cancer prevention

Ambry Genetics introduces BRCA1 and BRCA2 analysis

Penn Medicine researchers identify key molecular player in recurrent breast cancer

HEXIM1 gene makes heart healthier, suppresses breast cancer metastasis

Viewpoints: Administration 'finally' comes around on Plan B; 'Legal loophole' creates another compounded drug scare

Black women with breast cancer experience treatment delays, new study finds

Eribulin shows increased benefit among women sharing certain traits

Research: Breast cancer screening does not show effect on mortality statistics

Integrating exercise into cancer follow-up care can improve recovery, say Miriam Hospital researchers

PET and MR imaging can improve quality of life and survival for advanced breast cancer patients

Viewpoints: Selling Obamacare in Arizona; 'Hassle-free' marketplace; Seeking the 'grand bargain'

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Breast Cancer News and Research

Latest Breast Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in